IPP Bureau
Wacker acquires Spain-based biotech firm ADL BioPharma
By IPP Bureau - May 08, 2023
The acquisition of ADL BioPharma now makes WACKER owner of the entire plant, with total fermentation capacities of just under 3,000 cubic meters
Lupin to acquire French pharmaceutical company Medisol
By IPP Bureau - May 07, 2023
The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU
Tatva Chintan Pharma Chem posts Q4FY23 consolidated PAT at Rs. 16.95 Cr
By IPP Bureau - May 07, 2023
Tatva Chintan Pharma Chem has reported total income of Rs. 125.35 crores during the period ended March 31, 2023
Alembic Pharmaceuticals posts Q4FY2023 consolidated PAT at Rs. 152.60 Cr
By IPP Bureau - May 07, 2023
The company has reported total income of Rs. 1407.34 crores during the period ended March 31, 2023
Ajanta pharma posts Q4FY23 consolidated PAT at Rs. 122.25 Cr
By IPP Bureau - May 06, 2023
The company has reported total income of Rs. 918.67 crores during the period ended March 31, 2023
Briefs: Dr. Reddy's Laboratories
By IPP Bureau - May 06, 2023
USFDA has issued Form 483 with one observation
CORONA Remedies collaborates with Ferring Pharmaceuticals to commercialize maternal health & urology products in India
By IPP Bureau - May 06, 2023
The collaboration between CORONA and Ferring will cater to patients across India
India is emerging as a favourable destination to conduct clinical trials: PwC-USAIC Report
By IPP Bureau - May 05, 2023
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
Hyderabad startup’s Physiotherapy monitoring device ‘Pheezee’ receives USFDA
By IPP Bureau - May 05, 2023
Pheezee is designed to assess musculoskeletal and neuromuscular health.
PredOmix launches campaign for free cancer screening
By IPP Bureau - May 05, 2023
PredOmix has developed a novel blood test that can detect about 32 cancers in both men and women with 98 percent accuracy
Nouscom reaches clinical phase II using ProBioGen’s AGE1.CR.pIX production platform
By IPP Bureau - May 05, 2023
Nous-209 has been developed using the Nouscom's viral vector platform
Brain Cells are starved of energy when autophagy malfunctions: New Study
By IPP Bureau - May 05, 2023
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
Merck plans bioprocessing center in South Korea
By IPP Bureau - May 05, 2023
The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia-Pacific.
IMCD becomes new distributor for Evonik’s medical care polymer materials
By IPP Bureau - May 04, 2023
New agreement applies to the polymers of the Medical Care series portfolio
